Cargando…
Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial
BACKGROUND: To evaluate whether weekly schedules of docetaxel-based chemotherapy were superior to 3-weekly ones in terms of quality of life in locally advanced or metastatic breast cancer. METHODS: Patients with locally advanced or metastatic breast cancer, aged ≤ 70 years, performance status 0-2, c...
Autores principales: | Nuzzo, Francesco, Morabito, Alessandro, Gravina, Adriano, Di Rella, Francesca, Landi, Gabriella, Pacilio, Carmen, Labonia, Vincenzo, Rossi, Emanuela, De Maio, Ermelinda, Piccirillo, Maria Carmela, D'Aiuto, Giuseppe, Thomas, Renato, Rinaldo, Massimo, Botti, Gerardo, Di Bonito, Maurizio, Di Maio, Massimo, Gallo, Ciro, Perrone, Francesco, de Matteis, Andrea |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050853/ https://www.ncbi.nlm.nih.gov/pubmed/21324184 http://dx.doi.org/10.1186/1471-2407-11-75 |
Ejemplares similares
-
Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience
por: De Maio, Ermelinda, et al.
Publicado: (2005) -
Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial
por: De Maio, Ermelinda, et al.
Publicado: (2007) -
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial
por: Pacilio, C, et al.
Publicado: (2006) -
Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma
por: Gallo, Ciro, et al.
Publicado: (2006) -
Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series
por: Crispo, Anna, et al.
Publicado: (2013)